156 related articles for article (PubMed ID: 7564345)
1. Nitric oxide synthase blockade and renal vascular responses to norepinephrine and endothelin-1 in conscious dogs.
Fitzgerald SM; Evans RG; Christy IJ; Anderson WP
J Cardiovasc Pharmacol; 1995 Jun; 25(6):979-85. PubMed ID: 7564345
[TBL] [Abstract][Full Text] [Related]
2. Effects of NG-nitro-L-arginine on renal hemodynamic responses to endothelin-3 in anesthetized dogs.
Yamashita Y; Yukimura T; Miura K; Okumura M; Yamanaka S; Yamamoto K
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S332-4. PubMed ID: 1725372
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nitric oxide in endothelin ETB receptor-mediated inhibitory actions on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
Matsuo G; Matsumura Y; Tadano K; Hashimoto T; Morimoto S
J Cardiovasc Pharmacol; 1997 Sep; 30(3):325-31. PubMed ID: 9300316
[TBL] [Abstract][Full Text] [Related]
4. Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow.
Berthold H; Just A; Kirchheim HR; Ehmke H
Hypertension; 1999 Dec; 34(6):1254-8. PubMed ID: 10601127
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide mediates hepatic arterial vascular escape from norepinephrine-induced constriction.
Ming Z; Han C; Lautt WW
Am J Physiol; 1999 Dec; 277(6):G1200-6. PubMed ID: 10600817
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide in responses of regional kidney blood flow to vasoactive agents in anesthetized rabbits.
Rajapakse NW; Oliver JJ; Evans RG
J Cardiovasc Pharmacol; 2002 Aug; 40(2):210-9. PubMed ID: 12131550
[TBL] [Abstract][Full Text] [Related]
7. The role of basally synthesized nitric oxide in modulating the renal vasoconstrictor action of angiotensin II.
Aki Y; Tomohiro A; Nishiyama A; Kiyomoto K; Kimura S; Abe Y
Hypertens Res; 1997 Dec; 20(4):251-6. PubMed ID: 9453259
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of norepinephrine and angiotensin II-induced renal effects by NG-nitro-L-arginine, a nitric oxide synthase inhibitor.
Matsumura Y; Egi Y; Maekawa H; Miura A; Murata S; Morimoto S
Biol Pharm Bull; 1995 Apr; 18(4):496-500. PubMed ID: 7544660
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in modulating the long-term renal and hypertensive actions of norepinephrine.
Granger J; Schnackenberg C; Novak J; Tucker B; Miller T; Morgan S; Kassab S
Hypertension; 1997 Jan; 29(1 Pt 2):205-9. PubMed ID: 9039103
[TBL] [Abstract][Full Text] [Related]
10. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
Gellai M; De Wolf R; Fletcher T; Nambi P
Pharmacology; 1997 Dec; 55(6):299-308. PubMed ID: 9413859
[TBL] [Abstract][Full Text] [Related]
11. Renal actions of endothelin-1 and endothelin-3: interactions with the prostaglandin system and nitric oxide.
Chou SY; Porush JG
Am J Kidney Dis; 1995 Jul; 26(1):116-23. PubMed ID: 7541937
[TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin-3 on renal functions.
Yamashita Y; Yukimura T; Miura K; Okumura M; Yamamoto K
J Pharmacol Exp Ther; 1991 Dec; 259(3):1256-60. PubMed ID: 1762073
[TBL] [Abstract][Full Text] [Related]
13. Effect of L-NG-nitro-arginine, inhibitor of nitric oxide synthesis, on autoregulation of renal blood flow in dogs.
Kiyomoto H; Matsuo H; Tamaki T; Aki Y; Hong H; Iwao H; Abe Y
Jpn J Pharmacol; 1992 Feb; 58(2):147-55. PubMed ID: 1507520
[TBL] [Abstract][Full Text] [Related]
14. Determinants of renal vasoconstriction after systemic inhibition of nitric oxide synthesis in rats.
Brand-Schieber E; Pucci M; Nasjletti A
Am J Physiol; 1996 Jun; 270(6 Pt 2):R1203-7. PubMed ID: 8764283
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal infusions of endothelin in conscious dogs: interactions with prostanoids and angiotensin II.
Anderson WP; Heguilen RM; Woods RL
J Cardiovasc Pharmacol; 1995 Oct; 26(4):511-7. PubMed ID: 8569208
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 may be a physiologic modulator of vasoconstriction in rat kidney.
Reid JJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S267-70. PubMed ID: 7509962
[TBL] [Abstract][Full Text] [Related]
17. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension.
Kanagy NL
Am J Physiol; 1997 Dec; 273(6):H2756-64. PubMed ID: 9435612
[TBL] [Abstract][Full Text] [Related]
18. Interaction between nitric oxide and angiotensin II on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
Egi Y; Matsumura Y; Miura A; Murata S; Morimoto S
J Cardiovasc Pharmacol; 1995 Feb; 25(2):187-93. PubMed ID: 7752643
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of the nitric oxide synthase inhibitor, L-NG-nitroarginine, in dogs.
Yukimura T; Yamashita Y; Miura K; Okumura M; Yamanaka S; Yamamoto K
Am J Hypertens; 1992 Jul; 5(7):484-7. PubMed ID: 1379051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
